| Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised … G Attard, L Murphy, NW Clarke, W Cross, RJ Jones, CC Parker, ... The lancet 399 (10323), 447-460, 2022 | 282 | 2022 |
| Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab S Lin, NA Kennedy, A Saifuddin, DM Sandoval, CJ Reynolds, RC Seoane, ... Nature communications 13 (1), 1379, 2022 | 86 | 2022 |
| Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476) ND James, NW Clarke, A Cook, A Ali, AP Hoyle, G Attard, CD Brawley, ... International Journal of Cancer 151 (3), 422-434, 2022 | 68 | 2022 |
| Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): An open-label, non … JE Brown, KL Royle, W Gregory, C Ralph, A Maraveyas, O Din, T Eisen, ... The Lancet Oncology 24 (3), 213-227, 2023 | 60 | 2023 |
| Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two … G Attard, L Murphy, NW Clarke, A Sachdeva, C Jones, A Hoyle, W Cross, ... The Lancet Oncology 24 (5), 443-456, 2023 | 48 | 2023 |
| Utilization of Hyperion data over Dongargarh, India, for mapping altered/weathered and clay minerals along with field spectral measurements S Bhattacharya, TJ Majumdar, AS Rajawat, MK Panigrahi, PR Das International journal of remote sensing 33 (17), 5438-5450, 2012 | 38 | 2012 |
| Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators. Abiraterone acetate and prednisolone with or without … G Attard, L Murphy, NW Clarke, W Cross, RJ Jones, CC Parker, ... Lancet 399 (10323), 447-460, 2022 | 32 | 2022 |
| Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: final results of the POUT trial AJ Birtle, R Jones, J Chester, R Lewis, K Biscombe, M Johnson, A Blacker, ... Journal of Clinical Oncology 42 (13), 1466-1471, 2024 | 29 | 2024 |
| Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in … CC Parker, H Kynaston, AD Cook, NW Clarke, CN Catton, WR Cross, ... The Lancet 403 (10442), 2416-2425, 2024 | 26 | 2024 |
| Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the … CC Parker, NW Clarke, AD Cook, H Kynaston, CN Catton, WR Cross, ... The Lancet 403 (10442), 2405-2415, 2024 | 21 | 2024 |
| Docetaxel for nonmetastatic prostate cancer: long-term survival outcomes in the STAMPEDE randomized controlled trial ND James, FC Ingleby, NW Clarke, CL Amos, G Attard, CD Brawley, ... JNCI cancer spectrum 6 (4), pkac043, 2022 | 13 | 2022 |
| Absolute Value Like Fuzzy Real Number and Fuzzy Real-valued Sequence Space NR Das, P Das, A Choudhury JOURNAL OF FUZZY MATHEMATICS 4, 421-434, 1996 | 9 | 1996 |
| Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape A Ghose, P Lapitan, V Apte, A Ghosh, A Kandala, S Basu, J Parkes, ... Current Oncology Reports, 1-14, 2024 | 4 | 2024 |
| Patient characteristics, treatment patterns, and outcomes for patients with renal cell carcinoma in England: a retrospective cohort study P Das, A Booth, R Donaldson, N Berfeld, B Nordstrom, R Carroll, ... Clinical Genitourinary Cancer, 102081, 2024 | 3 | 2024 |
| Multi-centre prospective evaluation of cognitive function in patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) or … A Bahl, A Challapalli, AJ Birtle, E Foulstone, E Renninson, L Ashurst, ... Journal of Clinical Oncology 42 (4_suppl), 20-20, 2024 | 3 | 2024 |
| Is radical radiotherapy effective for elderly patients with muscle invasive bladder cancer? J Price, M Sivanandan, R Elmusharaf, PR Chakraborti, M Smith-Howell, ... Journal of Clinical Oncology 36 (6_suppl), 506-506, 2018 | 3 | 2018 |
| Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UK HA Payne, S Jain, C Peedell, A Edwards, JA Thomas, P Das, ... BMJ open 12 (7), e060506, 2022 | 2 | 2022 |
| Abiraterone acetate plus Prednisone/Prednisolone compared with Enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy: A retrospective … P Das, S Taylor, J Price, M Jones, C Martin‐Fernandez, A Ali, ... BJUI compass 1 (1), 21-31, 2020 | 2 | 2020 |
| Outcome of Abiraterone in metastatic prostate Cancer: an audit to asses real life experience in Northern Ireland P Das, L Shum, D Mitchel Clin Oncol (R Coll Radiol) 26, S5, 2014 | 2 | 2014 |
| SOME ASPECTS OF CONSTRUCTION OF A PERSONALITY INVENTORY OF ADOPTER-FARMERS AK Majumdar, DR Sarkar, PR Das, M Roy Indian Journal of Extension Education 2 (3&4), 133-135, 1966 | 2 | 1966 |